Create Alert
Watchlist

Torrent Pharmaceuticals

₹3,800.30
+40.80 (1.09%) 1D
NSE
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this

Performance

Open
3,748.00
Prev. Close
3,759.50
Volume
1,50,394
Total traded value
57.15 Cr
Upper Circuit
4,180.30
Lower Circuit
3,420.30

Fundamentals

Market Cap₹1,27,236Cr
ROE25.33%
P/E Ratio(TTM)59.46
EPS(TTM)63.23
P/B Ratio15.06
Dividend Yield0.16%
Industry P/E33.18
Book Value249.66
Debt to Equity0.33
Face Value5
Understand Fundamentals

Financials

*All values are in Rs. Cr
No Graph Data To Display
Quarterly
Yearly

About Torrent Pharma

Torrent Pharmaceuticals is a leading player in the Indian pharmaceutical sector, concentrating on treatments for chronic and sub-chronic therapeutic segments like heart and nerve-related ailments. The company's vision is to become the most respected pharma company, driven by its mission to provide total customer care with world-class products and services. It was established by founder Shri U.N. Mehta with the goal of serving the nation by providing high-quality medicines at affordable prices. A pioneer of niche marketing in India, the company focuses on therapeutic areas like Cardiovascular (CV) and Central Nervous System (CNS) to make important medicines available. Beyond its significant operations across India, the company has a strong global presence, operating in more than 40 countries including Brazil, Germany, and the United States. This focused strategy has positioned Torrent Pharma as the 5th largest company in the Indian Pharmaceutical Market, reflecting its strong brand recognition and market penetration.;
Parent OrganisationTorrent Pharmaceuticals Limited
Managing DirectorNA
NSE SymbolTORNTPHARM

Shareholding Pattern

Sep '24
Dec '24
Mar '25
Jun '25
Sep '25
Promoters
68.31%
Foreign Institutions
15.92%
Retail And Others
6.49%
Mutual Funds
5.12%
Other Domestic Institutions
4.16%

Similar Stocks

COMPANY
52 WEEK
MARKET PRICE
P/E Ratio
Ajanta Pharma
NA
(0.00%)
33.38
Gland Pharma
NA
(0.00%)
34.73
Eris Lifesciences
NA
(0.00%)
47.12
Sai Life Sciences
NA
(0.00%)
64.34
2025
7
Nov
Quarterly Result
Release date
28
Jul
Quarterly Result
Release date

20
Jun
Dividend
Ex date
₹6.00
per share

For each share you hold, you will receive ₹6.00
Dividend amount₹6.00 per share
Dividend TypeFinal
Ex Date20 Jun ‘25
Record Date20 Jun ‘25
Announcement date20 May ‘25

20
May
Dividend
Announced
₹6.00
per share

For each share you hold, you will receive ₹6.00
Dividend amount₹6.00 per share
Dividend TypeFinal
Ex Date20 Jun ‘25
Record Date20 Jun ‘25
Announcement date20 May ‘25
20
May
Annual Result
Release date

31
Jan
Dividend
Ex date
₹26.00
per share

For each share you hold, you will receive ₹26.00
Dividend amount₹26.00 per share
Dividend TypeInterim
Ex Date31 Jan ‘25
Record Date1 Feb ‘25
Announcement date24 Jan ‘25

24
Jan
Dividend
Announced
₹26.00
per share

For each share you hold, you will receive ₹26.00
Dividend amount₹26.00 per share
Dividend TypeInterim
Ex Date31 Jan ‘25
Record Date1 Feb ‘25
Announcement date24 Jan ‘25
24
Jan
Quarterly Result
Release date
2024
25
Oct
Quarterly Result
Release date
23
Jul
Quarterly Result
Release date

21
Jun
Dividend
Ex date
₹6.00
per share

For each share you hold, you will receive ₹6.00
Dividend amount₹6.00 per share
Dividend TypeFinal
Ex Date21 Jun ‘24
Record Date21 Jun ‘24
Announcement date24 May ‘24

24
May
Dividend
Announced
₹6.00
per share

For each share you hold, you will receive ₹6.00
Dividend amount₹6.00 per share
Dividend TypeFinal
Ex Date21 Jun ‘24
Record Date21 Jun ‘24
Announcement date24 May ‘24
24
May
Result
Release date

12
Feb
Dividend
Ex date
₹22.00
per share

For each share you hold, you will receive ₹22.00
Dividend amount₹22.00 per share
Dividend TypeInterim
Ex Date12 Feb ‘24
Record Date12 Feb ‘24
Announcement date2 Feb ‘24

2
Feb
Dividend
Announced
₹22.00
per share

For each share you hold, you will receive ₹22.00
Dividend amount₹22.00 per share
Dividend TypeInterim
Ex Date12 Feb ‘24
Record Date12 Feb ‘24
Announcement date2 Feb ‘24
Events calendar
View upcoming events in other stocks